1. Home
  2. FEIM vs ETON Comparison

FEIM vs ETON Comparison

Compare FEIM & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FEIM
  • ETON
  • Stock Information
  • Founded
  • FEIM 1961
  • ETON 2017
  • Country
  • FEIM United States
  • ETON United States
  • Employees
  • FEIM N/A
  • ETON N/A
  • Industry
  • FEIM Electrical Products
  • ETON Biotechnology: Pharmaceutical Preparations
  • Sector
  • FEIM Industrials
  • ETON Health Care
  • Exchange
  • FEIM Nasdaq
  • ETON Nasdaq
  • Market Cap
  • FEIM 224.9M
  • ETON 428.5M
  • IPO Year
  • FEIM N/A
  • ETON 2018
  • Fundamental
  • Price
  • FEIM $22.51
  • ETON $14.45
  • Analyst Decision
  • FEIM
  • ETON Strong Buy
  • Analyst Count
  • FEIM 0
  • ETON 3
  • Target Price
  • FEIM N/A
  • ETON $29.67
  • AVG Volume (30 Days)
  • FEIM 303.2K
  • ETON 616.4K
  • Earning Date
  • FEIM 07-21-2025
  • ETON 08-07-2025
  • Dividend Yield
  • FEIM 4.67%
  • ETON N/A
  • EPS Growth
  • FEIM 604.98
  • ETON N/A
  • EPS
  • FEIM 2.41
  • ETON N/A
  • Revenue
  • FEIM $65,400,999.00
  • ETON $48,327,000.00
  • Revenue This Year
  • FEIM N/A
  • ETON $103.21
  • Revenue Next Year
  • FEIM N/A
  • ETON $51.34
  • P/E Ratio
  • FEIM $8.88
  • ETON N/A
  • Revenue Growth
  • FEIM 24.10
  • ETON 40.88
  • 52 Week Low
  • FEIM $8.81
  • ETON $3.22
  • 52 Week High
  • FEIM $24.77
  • ETON $21.48
  • Technical
  • Relative Strength Index (RSI)
  • FEIM 54.24
  • ETON 41.91
  • Support Level
  • FEIM $20.34
  • ETON $13.51
  • Resistance Level
  • FEIM $24.50
  • ETON $14.70
  • Average True Range (ATR)
  • FEIM 1.56
  • ETON 0.78
  • MACD
  • FEIM -0.10
  • ETON 0.11
  • Stochastic Oscillator
  • FEIM 49.78
  • ETON 79.53

About FEIM Frequency Electronics Inc.

Frequency Electronics Inc is engaged in the design, development, and manufacture of high-precision timing, and frequency control products for space, air, sea, and terrestrial applications. The company has FEI-NY and FEI-Zyfer reportable segments. It derives the majority of its revenues from the FEI-NY segment. FEI-NY segment operations consist principally of precision time and frequency control products used in three principal markets namely communication satellites (both commercial and U.S. Government-funded); terrestrial cellular telephone or other ground-based telecommunication stations; and other components and systems for the U.S. military.

About ETON Eton Pharmaceuticals Inc.

Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.

Share on Social Networks: